Company / Current Assets
ARS Pharmaceuticals, Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$284.9M
FY2025
5-year range
$60.7M / $334.3M
FY2021-FY2025
Trend
-14.8%
vs FY2024
Sector context
#170 of 213
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s current assets of $285M is lower than 80% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 6 years, ranging from $61M in FY2021 to $391M in FY2020.
Based on SEC 10-K filings.
$285M in FY2025 with a 5-year CAGR of -6.1%.
Improved from $232M to $285M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +0.9%
- 5-Year CAGR
- -6.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 213This company $284.9M Sector average $2.5B
▼
-88.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -6.1%, indicating a declining trend.
- In FY2025, current assets decreased 14.8% year-over-year.
- Ranks #170 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $284.9M | -14.8% |
| FY2024 | $334.3M | +44.3% |
| FY2023 | $231.7M | -16.6% |
| FY2022 | $277.7M | +357.3% |
| FY2021 | $60.7M | -84.5% |
| FY2020 | $390.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026